EFNS guidelines on management of neurological problems in liver transplantation

European Journal of Neurology

Volumn 13, Issue 1, 2006, Pages 2-9

  Guarino, M ^a   Benito Leon, J ^b   Decruyenaere, J ^c   Schmutzhard, E ^d   Weissenborn, K ^e   Stracciari, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HOSPITAL DE MÓSTOLES   (Spain)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Immunosuppression neurotoxicity; Neurological manifestations; Orthotopic liver transplantation

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTICONVULSIVE AGENT; CALCINEURIN INHIBITOR; CASPOFUNGIN; CIDOFOVIR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; ETIRACETAM; FLUCONAZOLE; FLUCYTOSINE; FOSCARNET; GABAPENTIN; GANCICLOVIR; GENTAMICIN; HALOPERIDOL; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; NEUROLEPTIC AGENT; OKT 3; OLANZAPINE; QUETIAPINE; RAPAMYCIN; RIBOFLAVIN; RISPERIDONE; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; AKINETIC MUTISM; ARTICLE; ASPERGILLOSIS; BEHAVIOR DISORDER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL PONTINE MYELINOLYSIS; CEREBROSPINAL FLUID EXAMINATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONSENSUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EPILEPTIC STATE; EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; GRAND MAL SEIZURE; GUILLAIN BARRE SYNDROME; HEALTH CARE ORGANIZATION; HERPES; HUMAN; HUMAN HERPESVIRUS 6; HYPONATREMIA; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; LABORATORY TEST; LISTERIOSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; MIGRAINE; MYOPATHY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROTOXICITY; NOCARDIOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PERIOPERATIVE PERIOD; POLYNEUROPATHY; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SEIZURE; SPEECH DISORDER; STEROID THERAPY; TREATMENT INDICATION; TREMOR; WEAKNESS; WITHDRAWAL SEIZURE;

ADVISORY COMMITTEES; DISEASE MANAGEMENT; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; NERVOUS SYSTEM DISEASES; NEUROLOGY; SOCIETIES, MEDICAL;

EID: 33645211891     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01353.x     Document Type: Article

References (85)

1. Stracciari A Guarino M. Neuropsychiatric complications of liver transplantation. Metabolic Brain Disease 2001 16 3 11.
2. Pujol A Graus F Rimola A et al. Predictive factors of inhospital CNS complications following liver transplantation. Neurology 1994 44 1226 1230.
3. Guarino M Stracciari A Pazzaglia P et al. Neurological complications of liver transplantation. Journal of Neurology 1996 243 137 142.
4. Jones J Hunter D. Consensus methods for medical and health services research. British Medical Journal 1995 311 376 380.
5. Brainin M Barnes M Baron J-C et al. The preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. European Journal of Neurology 2004 11 577 581.
6. Guarino M Stracciari A D'Alessandro R et al. A prospective study on the neurological complications after liver transplantation. Gastroenterology International 1999 12 140 145.
7. Wijdicks EFM Wiesner RH Dahlke LJ Kron RAF. FK506-induced neurotoxicity in liver transplantation. Annals of Neurology 1994 35 498 501.
8. Kniepeiss D Iberer F Grasser B Schaffellner S Tscheliessnigg KH. Sirolimus and mycophenolate mofetil after liver transplantation. Transplant International 2003 16 504 509.
9. Moreno JM Rubio E Gomez A et al. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. Transplantation Proceedings 2003 35 1874 1876.
10. Maramottom BV Wijdicks EF. Sirolimus may not cause neurotoxicity in kidney and transplant recipients. Neurology 2004 63 1958 1959.
11. De Groen PC. Cyclosporine: a review and its specific use in liver transplantation. Mayo Clinic Proceedings 1989 64 680 689.
12. Thompson CB June CH Sullivan KM Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984 17 116 1120.
13. Textor SC Canzanello VJ Taler SJ et al. Cyclosporine-induced hypertension after transplantation. Mayo Clinic Proceedings 1994 69 1182 1193.
14. Wijdicks EFM Dahlke LJ Wiesner RH. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients. Neurology 1999 52 1708 1710.
15. Gomez R Moreno E Loinaz C et al. Liver transplantation with a twenty-four delay and an initial low dose of cyclosporine. Hepato-Gastroenterology 1996 43 435 439.
16. Trzepacz PT Gupta B Di Martini A. Pharmacologic issues in organ transplantation: psychopharmacology and neuropsychiatric medication side effects. In: Trzepacz PT Di Martini A. eds. The Transplant Patient. Cambridge Cambridge University Press 2000 pp. 187 213.
17. Prescott WA Jr. Callahan BL Park JM. Tacrolimus toxicity associated with concomitant metoclopramide therapy. Pharmacotherapy 2004 24 532 537.
18. Kabeer MH Filo RS Milgrom ML et al. Central pontine myelinolysis following orthotopic liver transplant:association with cyclosporin toxicity. Postgraduate Medical Journal 1995 71 239 241.
19. Fryer JP Fortier MV Metrakos P et al. Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. Transplantation 1996 61 658 661.
20. Rodriguez J Benito-Leon J Molina JA Ramos A Bermejo F. Central pontine myelinolisis associated with cyclosporin in liver transplantation. Neurologia 1998 13 437 440.
21. Ravaioli M Guarino M Stracciari A et al. Speech disorder related to tacrolimus-induced pontine myelinolysis after orthotopic liver transplantation. Transplant International 2003 16 605 607.
22. Appignani BA Bhadella RA Blacklow SC Wang AK Roland SF Freeman RB. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR. American Journal of Roentgenology 1996 166 683 688.
23. Bianco F Fattapposta F Locuratolo N et al. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology 2004 62 981 983.
24. Pratschke J Neuhaus R Tullius SG et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation 1997 64 938 940.
25. Abouljoud MS Kumar MS Brayman KL Emre S Bynon JS OLN Study Group Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clinical Transplantation 2002 16 168 172.
26. McAlister VC Peltekian KM Malatjalian DA et al. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. Liver Transplantation 2001 7 701 708.
27. Pfitzmann R Klupp J Langrehr JM et al. Mycophenolate mofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003 76 130 136.
28. Casanova B Prieto M Deya E et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. Liver Transplantation and Surgery 1997 3 638 640.
29. Rozen TD Wijdicks EF Hay JE. Treatment-refractory cyclosporine-associated headache. Relief with conversion to FK-506. Neurology 1996 47 1347.
30. Parizel PM Snoek H-W van den Hauwe L et al. Cerebral complications of murine monoclonal CD3 antobody (OKT3): CT and MRI findings. AJNR. American Journal of Neuroradiology 1997 18 1935 1938.
31. Rossi SJ Schroeder TJ Hariharan S First MR. Prevention and management of the adverse effects associated with immunosuppressive therapy. Drug Safety 1993 9 104 131.
32. Rosener M Martin E Zipp F Dichgans J Martin R. Neurological side-effects of pharmacologic corticoid therapy. Nervenarzt 1996 67 983 986.
33. Wijdicks EFM Plevak DJ Wiesner RH Steers JL. 1996a Causes and outcome of seizures in liver transplant recipients. Neurology 47 1523 1525.
34. Choi EJ Kang JK Lee SA Kim KH Lee SG Andermann F. New-onset seizures after liver transplantation: clinical implications and prognosis in survivors. European Neurology 2004 52 230 236.
35. Wszolek ZK Steg RE. Seizures after orthotopic liver transplantation. Seizure 1997 6 31 39.
36. Scottish Intercollegiate Guidelines Network Diagnosis and Management of Epilepsy in Adults. Edinburgh SIGN 2004
37. Adams DH Gunson B Honigsberger L et al. Neurological complications following liver transplantation. Lancet 1987 1 949 951.
38. Chabolla DR Harnois DM Meschia JF. Levetiracetam monotherapy for liver transplant patients with seizures. Transplantation Proceedings 2003 35 1480 1481.
39. Treiman DM Meyers PD Walton NY et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. New England Journal of Medicine 1998 339 792 798.
40. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. Journal of Neurology, Neurosurgery and Psychiatry 2004 75 Suppl. 3 22 28.
41. Wijdicks EFM Blue PR Steers JL Wiesner RH. 1996b Central pontine myelinolysis with stupor alone after orthotopic liver transplantation. Liver Transplantation and Surgery 2 14 16.
42. Bonham CA Dominguez EA Fukui MB et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998 66 1596 1604.
43. Bronster DJ Emre S Boccagni P Sheiner PA Schwartz ME Miller CM. Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up. Clinical Transplantation 2000 14 1 7.
44. Kato T Hattori H Nagato M et al. Subclinical central pontine myelinolysis following liver transplantation. Brain and Development 2002 24 179 182.
45. Abbasoglu O Goldstein RM Vodapally MS Jennings LW Husberg BS Klintmalm GB. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clinical Transplantation 1998 12 263 269.
46. Yu J Zheng SS Liang TB Shen Y Wang WL Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World Journal of Gastroenterology 2004 10 2540 2543.
47. Oya S Tsutsumi K Ueki K Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 2001 57 1931 1932.
48. Ruzek KA Campeau NG Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR. American Journal of Neuroradiology 2004 25 210 213.
49. Wijdicks EFM Litchy WJ Wiesner RH Krom RA. 1996c Neuromuscular complications associated with liver transplantation. Muscle and Nerve 19 696 700.
50. Campellone JV Lacomis D Giuliani MJ Kramer DJ. Mononeuropathies associated with liver transplantation. Muscle and Nerve 1998a 21 896 901.
51. Santilli IM Jann S Sterzi R et al. Neuromuscular complications of orthotopic liver transplantation. Gastroenterology International 1999 12 151 154.
52. Katirji MB. Brachial plexus injury following liver transplantation. Neurology 1989 39 736 738.
53. Campellone JV Lacomis D Kramer DJ Van Cott AC Giuliani MJ. Acute myopathy after liver transplantation. Neurology 1998b 50 46 53.
54. Mirò O Salmeron JM Masanes F et al. Acute quadriplegic myopathy with myosin-deficient muscle fibres after liver transplantation. Transplantation 1999 67 1144 1151.
55. Rezaiguia-Delclaux S q3 Lefaucher JP Zakkouri M Duvoux C Duvaldestin P Stephan F. Severe acute polyneuropathy complicating orthotopic liver allograft failure. Transplantation 2002 74 880 882.
56. Goy JJ Stauffer JC Deruaz JP et al. Myopathy as possible side-effect of cyclosporin. Lancet 1989 1 1446 1447.
57. Ayres RCS Dousset B Wixon S Buckels JAC McMaster P Mayer AD. Peripheral neuropathy with tacrolimus. Lancet 1994 343 862 863.
58. Bronster DJ Yonover P Stein J Scelsa SN Miller CM Sheiner PA. Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 1995a 59 1066 1068.
59. Campellone JV Lacomis D. Neuromuscular disorders. In: Wijdicks EFM. ed. Neurologic Complications in Organ Transplant Recipients. Boston, MA Butterworth-Heineman 1999 pp. 169 192.
60. El-Sabrout RA Radovancevic B Ankoma-Sey V Van Buren C. Guillain-Barrè syndrome after solid organ transplantation. Transplantation 2001 71 1311 1316.
61. Colle I Van Vlierberghe H Troisi R et al. Campylobacter-associated Guillain-Barre syndrome after orthotopic liver transplantation for hepatitis C cirrhosis: a case report. Hepatology Research 2002 24 205.
62. Taylor BV Wijdicks EFM Poterucha JJ Weisner RH. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation. Annals of Neurology 1995 38 828 831.
63. Echaniz-Laguna A Battaglia F Ellero B Mohr M Jaeck D. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. Muscle and Nerve 2004 30 501 504.
64. Warner MA. Perioperative neuropathies. Mayo Clinic Proceedings 1998 73 567 574.
65. Motomura M. Critical illness polyneuropathy and myopathy. Rinsho Shinkeigaku. Clinical Neurology 2003 43 802 804.
66. Van den Berghe G Wouters P Weekers F et al. Intensive insulin treatment reduced mortality and morbidity in critically ill patients. New England Journal of Medicine 2001 345 1359 1367.
67. Wijdicks EFM De Groen PC Wiesner RH Kron RAF. Intracerebral hemorrhage in liver transplant recipients. Mayo Clinic Proceedings 1995 70 443 446.
68. Wang WL Yang ZF Lo CM Liu CL Fan ST. Intracerebral hemorrhage after liver transplantation. Liver Transplantation 2000 6 345 348.
69. Singh N Yu VL Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine 1994 73 110 118.
70. Adair JC. Cerebrovascular disorders. In: Wijdicks EFM. ed. Neurologic Complications in Organ Transplant Recipients. Boston, MA Butterworth-Heineman 1999 pp. 193 216.
71. Plachky J Hofer S Volkmann M Martin E Bardenheuer HJ Weigand MA. Regional cerebral oxygen saturation is a sensitive marker of cerebral hypoperfusion during orthotopic liver transplantation. Anesthesia and Analgesia 2004 99 344 349.
72. Tolkoff-Rubin NE Hovingh KG Rubin RH. Central nervous system infections. In: Wijdicks EFM. ed. Neurologic Complications in Organ Transplant Recipients. Boston, MA Butterworth Heinemann 1999 pp. 141 168.
73. Singh N Husain S. Infections of the central nervous system in transplant recipients. Transplant Infectious Disease 2000 2 101 111.
74. Bronster DJ Lidov MW Wolfe D Schwartz ME Miller CM. Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transplantation and Surgery 1995b 1 371 372.
75. Portegies P Solod L Cinque P et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. European Journal of Neurology 2004 11 297 304.
76. Stone WJ Schaffner W. Strongyloides infections in transplant recipients. Seminars in Respiratory Infections 1990 5 58 64.
77. Soave R. Prophylaxis strategies for solid organ transplantation (2001). Clinical Infectious Diseases 2001 33 Suppl. 1 s26 31.
78. Saag MS Graybill RJ Larsen RA et al. Practice guidelines for the management of cryptococcal disease. Clinical Infectious Diseases 2000 30 710 718.
79. Ascioglu S Rex JH de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases 2002 34 7 14.
80. Herbrecht R Denning DW Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine 2002 347 408 415.
81. Böhme A Ruhnke M Buchheidt D et al. Treatment of fungal infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology 2003 82 Suppl. 2 S133 140.
82. Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004 11 Suppl.2 105A 111A.
83. Schwartz S Thiel E. Update on the treatment of cerebral aspergillosis. Annals of Hematology 2004 831 S42 S44.
84. Wu G Vilchez RA Eidelman B Fung J Kormos R Kusne S. Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients. Transplant Infectious Disease 2002 4 183 188.
85. Venkataramanan R Zang S Gayowski T Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrobial Agents and Chemotherapy 2002 46 3091 3093.